Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1108652

registered interest
date	01/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the effect of leaving the European Research Area on access to EU framework programme funding for UK-based cancer research projects.
tabling member constituency	Houghton and Sunderland South
tabling member printed	Bridget Phillipson
uin	239229
answer	answer is ministerial correction date of answer 04/04/2019 answer text <p>European Union Framework Programme funding for United Kingdom-based projects, including those on cancer research, will not necessarily be linked to the UK’s involvement in the European Research Area.</p><p> </p><p>If we leave with the Withdrawal Agreement, UK participants will still be eligible for funding from Horizon 2020, including for cancer research projects. As a responsible Government, we are continuing to prepare for a ‘no deal’ scenario. In a ‘no deal’ scenario, the Government has committed to fund all successful UK bids to Horizon 2020 submitted before the end of 2020 and for the lifetime of projects. This guarantee will enable UK researchers and businesses to continue to access funding required to participate in Horizon 2020 and will support ongoing world-leading collaboration, including in cancer research.</p><p> </p><p>Looking beyond Horizon 2020, in any scenario we want to continue to back the UK research and innovation community by supporting the provision of opportunities for world-class collaborative research. We are continuing to seek a relationship with the European Union on science and innovation including the option of future association to excellence-based EU research and innovation funding programmes.</p><p> </p><p>National Institute for Health Research cancer research expenditure has risen from £101 million in 2010/11 to £136 million in 2017/18. This constitutes the largest investment in a disease area. A large proportion of this funding comprises support for the delivery of Cancer Research UK-funded research in the National Health Service.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 04/04/2019 11:13:19 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4046 label Biography information for Bridget Phillipson

1108655

registered interest
date	01/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dyspraxia
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential effect on the (a) time taken to receive and (b) quality of assessments for dyspraxia of CCGs opting not to fund dyspraxia assessments with Dyspraxia UK; and if he will make a statement.
tabling member constituency	South Shields
tabling member printed	Mrs Emma Lewell-Buck
uin	239251
answer	answer is ministerial correction date of answer 04/04/2019 answer text <p>We have made no such assessment. Commissioning decisions are made locally by clinical commissioning groups (CCGs). CCGs are best placed to do this as they are clinically led organisations that have both the local knowledge and local accountability to make commissioning decisions in the best interests of their populations.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 04/04/2019 11:14:39 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4277 label Biography information for Mrs Emma Lewell-Buck

1108671

registered interest
date	01/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Barts Health NHS Trust: Breast Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of trends in the number of symptomatic breast appointments in Barts Health NHS Trust in each of the last five years.
tabling member constituency	East Ham
tabling member printed	Stephen Timms
uin	239164
answer	answer is ministerial correction date of answer 04/04/2019 answer text <p>The following table provides a summary of referrals to Barts Health NHS trust for suspected breast cancer under the national two week wait operational standards, both for urgent general practitioner suspected cancer and for the symptomatic breast two week standard.</p><p> </p><table><tbody><tr><td><p>Symptomatic Breast Referrals</p></td><td><p>2013-14</p></td><td><p>2014-15</p></td><td><p>2015-16</p></td><td><p>2016-17</p></td><td><p>2017-18</p></td><td><p>2018-19 (Year to Date)</p></td></tr><tr><td><p>Barts Health</p></td><td><p>2,920</p></td><td><p>2,763</p></td><td><p>3,318</p></td><td><p>2,736</p></td><td><p>1,706</p></td><td><p>2,247</p></td></tr></tbody></table> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 04/04/2019 11:07:55 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	163 label Biography information for Sir Stephen Timms

1108672

registered interest
date	01/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what proportion of women were invited for screening at Central and East London Breast Screening Service within three years of their previous appointment in each month in the last three years.
tabling member constituency	East Ham
tabling member printed	Stephen Timms
uin	239165
answer	answer is ministerial correction date of answer 04/04/2019 answer text <p>This information is not held centrally in the format requested.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 04/04/2019 11:06:16 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	163 label Biography information for Sir Stephen Timms

1108673

registered interest
date	01/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many screening sessions have been delivered by Central and East London Breast Screening Service (a) in Homerton Hospital and (b) at the Sir Ludwig Guttmann Health and Wellbeing Centre in each week in the last year.
tabling member constituency	East Ham
tabling member printed	Stephen Timms
uin	239166
answer	answer is ministerial correction date of answer 04/04/2019 answer text <p>This information is not held centrally in the format requested.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 239167 question first answered 04/04/2019 11:08:46 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	163 label Biography information for Sir Stephen Timms

1108674

registered interest
date	01/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, in which months in the last two years Central and East London Breast Screening Service has met its target of less than 2 per cent of screenings being subject to technical recalls.
tabling member constituency	East Ham
tabling member printed	Stephen Timms
uin	239167
answer	answer is ministerial correction date of answer 04/04/2019 answer text <p>This information is not held centrally in the format requested.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 239166 question first answered 04/04/2019 11:08:46 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	163 label Biography information for Sir Stephen Timms

1108712

registered interest
date	01/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Skin Diseases: Prescriptions
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that the prescribing practices of Clinical Commissioning Groups follows the appropriate clinical guidelines set by NICE or NHS England on the use of emollients for patients with inflammatory skin conditions.
tabling member constituency	North Tyneside
tabling member printed	Mary Glindon
uin	239233
answer	answer is ministerial correction date of answer 05/04/2019 answer text <p>The Department and NHS England expects clinical commissioning groups (CCGs) to take both NHS England and National Institute for Health and Care Excellence guidance into account in formulating local polices, and for prescribers to reflect local policies in their prescribing practice.</p><p> </p><p>In March 2018, CCG guidance was published on conditions for which over the counter items should not be routinely prescribed in primary care. This covers 35 minor conditions, including recommendations on the use of emollients for self-care of mild dry skin. The recommendation in this guidance only applies to those with mild dry skin or mild irritant dermatitis. If CCGs have implemented the guidance as intended, patients with moderate to severe eczema will still be able to receive their emollients on prescription as it is a chronic condition.</p><p> </p><p>NHS England has also recently run a consultation on ‘Items which should not routinely be prescribed in primary care: an update and a consultation on further guidance for clinical commissioning groups (CCGs)’. This included proposals around the proscribing of emollient bath and shower preparations (it did not cover all emollients, which come in a range of other formulations).</p><p> </p><p>Variation of prescribing of emollient bath and shower preparations was reviewed and published as part of the consultation undertaken from 28 November 2018 – 28 February 2019. Details of this are available in the consultation document at the following link:</p><p> </p><p><a href="https://www.engage.england.nhs.uk/consultation/items-routinely-prescribed-update/user_uploads/low-priority-prescribing-consultation-guidance.pdf" target="_blank">https://www.engage.england.nhs.uk/consultation/items-routinely-prescribed-update/user_uploads/low-priority-prescribing-consultation-guidance.pdf</a></p><p> </p><p>NHS England is currently taking account of all consultation responses and updated CCG guidance is due to be published in the summer of 2019.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 238640 question first answered 05/04/2019 11:04:45 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4126 label Biography information for Mary Glindon

1108736

registered interest
date	01/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Epilepsy: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will confirm that Serious Medicines Shortage Protocols will not be appropriate for epilepsy treatments and that will be included in published guidance on Serious Medicines Protocols.
tabling member constituency	Bury South
tabling member printed	Mr Ivan Lewis
uin	239183
answer	answer is ministerial correction date of answer 04/04/2019 answer text <p>A Serious Shortage Protocol is an additional tool to manage and mitigate medication shortages and may be used in the exceptional and rare situation when other measures have been exhausted or are likely to be ineffective.</p><p> </p><p>As the explanatory memorandum of the amending Statutory Instrument acknowledges, Protocols for therapeutic or generic equivalents will not be suitable for all medicines and patients. For example, those types of protocols would not be suitable for treatments for epilepsy or treatments requiring biological products where the medicines that are prescribed need to be prescribed by brand for clinical reasons. In these cases, patients would always be referred back to the prescriber for any decision about their treatment before any therapeutic or generic alternative is supplied.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 04/04/2019 11:09:34 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	441 label Biography information for Mr Ivan Lewis

1108746

registered interest
date	01/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Visual Impairment: Surgery
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment on the effect of the changes to the NHS tariff for combined cataract and glaucoma surgery on (a) hospital costs and (b) efficiency in the field of ophthalmology.
tabling member constituency	Dudley North
tabling member printed	Ian Austin
uin	239204
answer	answer is ministerial correction date of answer 04/04/2019 answer text <p>There has been a significant change in clinical practice in ophthalmology since the last tariff prices were set and reference costs used to calculate prices were collected, with a shift to performing Minimally Invasive Glaucoma Surgery (MIGS) instead of open glaucoma procedures which are frequently combined with cataract extraction.</p><p> </p><p>MIGS are significantly cheaper, and both procedures cannot be differentiated using operating procedure code supplement codes. Open/tube glaucoma procedures are nearly always done with a graft of sclera or tutoplast, which triggers multiple procedures so will receive significantly more under the 2019/20 prices than MIGS procedures, which is appropriate.</p><p> </p><p>NHS Improvement has carried out an impact assessment which shows that the national tariff changes should not affect patient access to glaucoma treatment.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 239205 question first answered 04/04/2019 11:12:13 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	1511 label Biography information for Lord Austin of Dudley

1108747

registered interest
date	01/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Glaucoma: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the effectiveness of the changes to the NHS tariff for 2019-2020 in the field of ophthalmology on patient access to glaucoma treatment.
tabling member constituency	Dudley North
tabling member printed	Ian Austin
uin	239205
answer	answer is ministerial correction date of answer 04/04/2019 answer text <p>There has been a significant change in clinical practice in ophthalmology since the last tariff prices were set and reference costs used to calculate prices were collected, with a shift to performing Minimally Invasive Glaucoma Surgery (MIGS) instead of open glaucoma procedures which are frequently combined with cataract extraction.</p><p> </p><p>MIGS are significantly cheaper, and both procedures cannot be differentiated using operating procedure code supplement codes. Open/tube glaucoma procedures are nearly always done with a graft of sclera or tutoplast, which triggers multiple procedures so will receive significantly more under the 2019/20 prices than MIGS procedures, which is appropriate.</p><p> </p><p>NHS Improvement has carried out an impact assessment which shows that the national tariff changes should not affect patient access to glaucoma treatment.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 239204 question first answered 04/04/2019 11:12:13 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	1511 label Biography information for Lord Austin of Dudley